Garda Capital Partners LP Makes New Investment in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Garda Capital Partners LP purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 14,376 shares of the exchange traded fund’s stock, valued at approximately $1,295,000. SPDR S&P Biotech ETF accounts for 0.1% of Garda Capital Partners LP’s holdings, making the stock its 29th largest position.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Golden State Wealth Management LLC bought a new position in shares of SPDR S&P Biotech ETF in the fourth quarter worth approximately $29,000. Avior Wealth Management LLC boosted its position in SPDR S&P Biotech ETF by 393.6% during the 4th quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock valued at $35,000 after buying an additional 307 shares during the period. Tidemark LLC grew its holdings in SPDR S&P Biotech ETF by 101.5% in the 3rd quarter. Tidemark LLC now owns 395 shares of the exchange traded fund’s stock worth $39,000 after acquiring an additional 199 shares during the last quarter. Quintet Private Bank Europe S.A. purchased a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at about $40,000. Finally, Bank of Jackson Hole Trust bought a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $43,000.

SPDR S&P Biotech ETF Trading Up 1.8 %

SPDR S&P Biotech ETF stock opened at $88.71 on Friday. The firm has a market cap of $5.85 billion, a P/E ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47. The firm has a 50-day moving average of $91.00 and a 200-day moving average of $95.76.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.